A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies

NCT05588440 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the available clinical data and capital requirements for continued development, the Company has decided to terminate this study.

Conditions

Interventions

Sponsor

Oncternal Therapeutics, Inc